Search and Browse
Download
Enter Data
| Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kJ/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Adenosine receptor A2b (Homo sapiens (Human)) | BDBM375232 (3-chloro-5-(3-fluoropyridin-4-yl)-6-(pyridin-4-yl)...) | NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 12 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Palobiofarma, S.L. US Patent | Assay Description The binding assay for adenosine A2B receptor subtype was carried out on human recombinant source (HEK-293 cells) and [3H]DPCPX as radioligand, accord... | US Patent US10253017 (2019) BindingDB Entry DOI: 10.7270/Q2ZP48FV | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A2b (Homo sapiens (Human)) | BDBM375233 (3-bromo-5-(3-fluoropyridin-4-yl)-6-(pyridin-4-yl)p...) | NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 13 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Palobiofarma, S.L. US Patent | Assay Description The binding assay for adenosine A2B receptor subtype was carried out on human recombinant source (HEK-293 cells) and [3H]DPCPX as radioligand, accord... | US Patent US10253017 (2019) BindingDB Entry DOI: 10.7270/Q2ZP48FV | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A2b (Homo sapiens (Human)) | BDBM375229 (3-chloro-5-(3-fluoropyridin-4-yl)-6-(pyridin-3-yl)...) | NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 23.9 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Palobiofarma, S.L. US Patent | Assay Description The binding assay for adenosine A2B receptor subtype was carried out on human recombinant source (HEK-293 cells) and [3H]DPCPX as radioligand, accord... | US Patent US10253017 (2019) BindingDB Entry DOI: 10.7270/Q2ZP48FV | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A2b (Homo sapiens (Human)) | BDBM375234 (3-chloro-5-(3-fluoropyridin-4-yl)-6-(6-methoxypyri...) | NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 24 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Palobiofarma, S.L. US Patent | Assay Description The binding assay for adenosine A2B receptor subtype was carried out on human recombinant source (HEK-293 cells) and [3H]DPCPX as radioligand, accord... | US Patent US10253017 (2019) BindingDB Entry DOI: 10.7270/Q2ZP48FV | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A2b (Homo sapiens (Human)) | BDBM375227 (3-chloro-6-(pyridin-3-yl)-5-(pyridin-4-yl)pyridin-...) | NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 34.5 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Palobiofarma, S.L. US Patent | Assay Description The binding assay for adenosine A2B receptor subtype was carried out on human recombinant source (HEK-293 cells) and [3H]DPCPX as radioligand, accord... | US Patent US10253017 (2019) BindingDB Entry DOI: 10.7270/Q2ZP48FV | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A2b (Homo sapiens (Human)) | BDBM375230 (3-bromo-5-(3-fluoropyridin-4-yl)-6-(pyridin-3-yl)p...) | NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 37 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Palobiofarma, S.L. US Patent | Assay Description The binding assay for adenosine A2B receptor subtype was carried out on human recombinant source (HEK-293 cells) and [3H]DPCPX as radioligand, accord... | US Patent US10253017 (2019) BindingDB Entry DOI: 10.7270/Q2ZP48FV | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A2b (Homo sapiens (Human)) | BDBM375228 (3-bromo-6-(pyridin-3-yl)-5-(pyridin-4-yl)pyridin-2...) | NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 46.1 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Palobiofarma, S.L. US Patent | Assay Description The binding assay for adenosine A2B receptor subtype was carried out on human recombinant source (HEK-293 cells) and [3H]DPCPX as radioligand, accord... | US Patent US10253017 (2019) BindingDB Entry DOI: 10.7270/Q2ZP48FV | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A2b (Homo sapiens (Human)) | BDBM375226 (5-(3-fluoropyridin-4-yl)-6-(pyridin-4-yl)pyridin-2...) | NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 149 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Palobiofarma, S.L. US Patent | Assay Description The binding assay for adenosine A2B receptor subtype was carried out on human recombinant source (HEK-293 cells) and [3H]DPCPX as radioligand, accord... | US Patent US10253017 (2019) BindingDB Entry DOI: 10.7270/Q2ZP48FV | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A2b (Homo sapiens (Human)) | BDBM375231 (3-chloro-6-(5-fluoropyridin-3-yl)-5-(3-fluoropyrid...) | NCI pathway Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 150 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Palobiofarma, S.L. US Patent | Assay Description The binding assay for adenosine A2B receptor subtype was carried out on human recombinant source (HEK-293 cells) and [3H]DPCPX as radioligand, accord... | US Patent US10253017 (2019) BindingDB Entry DOI: 10.7270/Q2ZP48FV | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A2a (Homo sapiens (Human)) | BDBM375228 (3-bromo-6-(pyridin-3-yl)-5-(pyridin-4-yl)pyridin-2...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 300 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Palobiofarma, S.L. US Patent | Assay Description The binding assay for adenosine A2B receptor subtype was carried out on human recombinant source (HEK-293 cells) and [3H]DPCPX as radioligand, accord... | US Patent US10253017 (2019) BindingDB Entry DOI: 10.7270/Q2ZP48FV | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A2a (Homo sapiens (Human)) | BDBM375227 (3-chloro-6-(pyridin-3-yl)-5-(pyridin-4-yl)pyridin-...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 500 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Palobiofarma, S.L. US Patent | Assay Description The binding assay for adenosine A2B receptor subtype was carried out on human recombinant source (HEK-293 cells) and [3H]DPCPX as radioligand, accord... | US Patent US10253017 (2019) BindingDB Entry DOI: 10.7270/Q2ZP48FV | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A2a (Homo sapiens (Human)) | BDBM375232 (3-chloro-5-(3-fluoropyridin-4-yl)-6-(pyridin-4-yl)...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 555 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Palobiofarma, S.L. US Patent | Assay Description The binding assay for adenosine A2B receptor subtype was carried out on human recombinant source (HEK-293 cells) and [3H]DPCPX as radioligand, accord... | US Patent US10253017 (2019) BindingDB Entry DOI: 10.7270/Q2ZP48FV | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A2a (Homo sapiens (Human)) | BDBM375233 (3-bromo-5-(3-fluoropyridin-4-yl)-6-(pyridin-4-yl)p...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 1.30E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Palobiofarma, S.L. US Patent | Assay Description The binding assay for adenosine A2B receptor subtype was carried out on human recombinant source (HEK-293 cells) and [3H]DPCPX as radioligand, accord... | US Patent US10253017 (2019) BindingDB Entry DOI: 10.7270/Q2ZP48FV | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A2a (Homo sapiens (Human)) | BDBM375229 (3-chloro-5-(3-fluoropyridin-4-yl)-6-(pyridin-3-yl)...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | 4.80E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Palobiofarma, S.L. US Patent | Assay Description The binding assay for adenosine A2B receptor subtype was carried out on human recombinant source (HEK-293 cells) and [3H]DPCPX as radioligand, accord... | US Patent US10253017 (2019) BindingDB Entry DOI: 10.7270/Q2ZP48FV | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A2a (Homo sapiens (Human)) | BDBM375226 (5-(3-fluoropyridin-4-yl)-6-(pyridin-4-yl)pyridin-2...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | >5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Palobiofarma, S.L. US Patent | Assay Description The binding assay for adenosine A2B receptor subtype was carried out on human recombinant source (HEK-293 cells) and [3H]DPCPX as radioligand, accord... | US Patent US10253017 (2019) BindingDB Entry DOI: 10.7270/Q2ZP48FV | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A2a (Homo sapiens (Human)) | BDBM375234 (3-chloro-5-(3-fluoropyridin-4-yl)-6-(6-methoxypyri...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | >5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Palobiofarma, S.L. US Patent | Assay Description The binding assay for adenosine A2B receptor subtype was carried out on human recombinant source (HEK-293 cells) and [3H]DPCPX as radioligand, accord... | US Patent US10253017 (2019) BindingDB Entry DOI: 10.7270/Q2ZP48FV | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A2a (Homo sapiens (Human)) | BDBM375230 (3-bromo-5-(3-fluoropyridin-4-yl)-6-(pyridin-3-yl)p...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | >5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Palobiofarma, S.L. US Patent | Assay Description The binding assay for adenosine A2B receptor subtype was carried out on human recombinant source (HEK-293 cells) and [3H]DPCPX as radioligand, accord... | US Patent US10253017 (2019) BindingDB Entry DOI: 10.7270/Q2ZP48FV | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Adenosine receptor A2a (Homo sapiens (Human)) | BDBM375231 (3-chloro-6-(5-fluoropyridin-3-yl)-5-(3-fluoropyrid...) | PDB MMDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | >5.00E+3 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Palobiofarma, S.L. US Patent | Assay Description The binding assay for adenosine A2B receptor subtype was carried out on human recombinant source (HEK-293 cells) and [3H]DPCPX as radioligand, accord... | US Patent US10253017 (2019) BindingDB Entry DOI: 10.7270/Q2ZP48FV | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Ribosyldihydronicotinamide dehydrogenase [quinone] (Homo sapiens (Human)) | BDBM375229 (3-chloro-5-(3-fluoropyridin-4-yl)-6-(pyridin-3-yl)...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 98 | n/a | n/a | n/a | n/a | n/a | n/a |
Palobiofarma, S.L. US Patent | Assay Description The experiment of binding to MT3 sites was carried out on hamster brain membranes using [125I]2-iodomelatonin as radioligand in accordance with the p... | US Patent US10253017 (2019) BindingDB Entry DOI: 10.7270/Q2ZP48FV | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Ribosyldihydronicotinamide dehydrogenase [quinone] (Homo sapiens (Human)) | BDBM375227 (3-chloro-6-(pyridin-3-yl)-5-(pyridin-4-yl)pyridin-...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 130 | n/a | n/a | n/a | n/a | n/a | n/a |
Palobiofarma, S.L. US Patent | Assay Description The experiment of binding to MT3 sites was carried out on hamster brain membranes using [125I]2-iodomelatonin as radioligand in accordance with the p... | US Patent US10253017 (2019) BindingDB Entry DOI: 10.7270/Q2ZP48FV | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Ribosyldihydronicotinamide dehydrogenase [quinone] (Homo sapiens (Human)) | BDBM375228 (3-bromo-6-(pyridin-3-yl)-5-(pyridin-4-yl)pyridin-2...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 140 | n/a | n/a | n/a | n/a | n/a | n/a |
Palobiofarma, S.L. US Patent | Assay Description The experiment of binding to MT3 sites was carried out on hamster brain membranes using [125I]2-iodomelatonin as radioligand in accordance with the p... | US Patent US10253017 (2019) BindingDB Entry DOI: 10.7270/Q2ZP48FV | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
| Ribosyldihydronicotinamide dehydrogenase [quinone] (Homo sapiens (Human)) | BDBM375231 (3-chloro-6-(5-fluoropyridin-3-yl)-5-(3-fluoropyrid...) | PDB MMDB Reactome pathway KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar | PC cid PC sid UniChem | US Patent | n/a | n/a | 250 | n/a | n/a | n/a | n/a | n/a | n/a |
Palobiofarma, S.L. US Patent | Assay Description The experiment of binding to MT3 sites was carried out on hamster brain membranes using [125I]2-iodomelatonin as radioligand in accordance with the p... | US Patent US10253017 (2019) BindingDB Entry DOI: 10.7270/Q2ZP48FV | |||||||||||
| More data for this Ligand-Target Pair | |||||||||||||
